<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Marut Yanaranop และ Surasith Chaithongwongwatthana. (2015) Intravenous versus oral regimens of dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in primary ovarian, fallopian tube and peritoneal cancer patients: a double-blind randomized controlled trial. Chulalongkorn University:ม.ป.ท.</APA><Chicago>Marut Yanaranop และ Surasith Chaithongwongwatthana. 2015. Intravenous versus oral regimens of dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in primary ovarian, fallopian tube and peritoneal cancer patients: a double-blind randomized controlled trial. ม.ป.ท.:Chulalongkorn University;</Chicago><MLA>Marut Yanaranop และ Surasith Chaithongwongwatthana.  Intravenous versus oral regimens of dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in primary ovarian, fallopian tube and peritoneal cancer patients: a double-blind randomized controlled trial.  ม.ป.ท.:Chulalongkorn University, 2015. Print.</MLA></bibliography></xml>
